APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sonidegib

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sonidegib Market Outlook and Growth Opportunities 2026

30 December 2025196 pages

Choose your research edition.

Industry ResearchSonidegib Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Sonidegib Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Sonidegib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sonidegib Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Sonidegib Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sonidegib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sonidegib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sonidegib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sonidegib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sonidegib market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sonidegib market include Sun Pharmaceutical Industries and Novartis among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sonidegib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sonidegib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sonidegib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sonidegib market size, projected growth trends, production technologies, key applications, and end-use industries.

Sonidegib Segment by Company

Sun Pharmaceutical Industries

Novartis

Sonidegib Segment by Type

Solution

Capsule

Sonidegib Segment by Application

Treating Basal Cell Carcinoma

Antitumor

Others

Sonidegib Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Sonidegib status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sonidegib market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sonidegib significant trends, drivers, influence factors in global and regions.

6. To analyze Sonidegib competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sonidegib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sonidegib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sonidegib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sonidegib market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sonidegib industry.

Chapter 3: Detailed analysis of Sonidegib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sonidegib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sonidegib in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sonidegib Industry Trends Table 2. Sonidegib Industry Drivers Table 3. Sonidegib Industry Opportunities and Challenges Table 4. Sonidegib Industry Restraints Table 5. Global Sonidegib Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sonidegib Revenue Share by Company (2021-2026) Table 7. Global Sonidegib Sales Volume by Company (Units) & (2021-2026) Table 8. Global Sonidegib Sales Volume Share by Company (2021-2026) Table 9. Global Sonidegib Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sonidegib Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sonidegib Key Company Manufacturing Base & Headquarters Table 12. Global Sonidegib Company, Product Type & Application Table 13. Global Sonidegib Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sonidegib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Solution Table 18. Significant Companies of Capsule Table 19. Global Sonidegib Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Sonidegib Sales Volume by Type (2021-2026) & (Units) Table 21. Global Sonidegib Sales Volume by Type (2027-2032) & (Units) Table 22. Global Sonidegib Sales Volume Share by Type (2021-2026) Table 23. Global Sonidegib Sales Volume Share by Type (2027-2032) Table 24. Global Sonidegib Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sonidegib Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sonidegib Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sonidegib Sales Value Share by Type (2021-2026) Table 28. Global Sonidegib Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Treating Basal Cell Carcinoma Table 30. Significant Companies of Antitumor Table 31. Significant Companies of Others Table 32. Global Sonidegib Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Sonidegib Sales Volume by Application (2021-2026) & (Units) Table 34. Global Sonidegib Sales Volume by Application (2027-2032) & (Units) Table 35. Global Sonidegib Sales Volume Share by Application (2021-2026) Table 36. Global Sonidegib Sales Volume Share by Application (2027-2032) Table 37. Global Sonidegib Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sonidegib Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sonidegib Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sonidegib Sales Value Share by Application (2021-2026) Table 41. Global Sonidegib Sales Value Share by Application (2027-2032) Table 42. Global Sonidegib Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Sonidegib Sales by Region (2021-2026) & (Units) Table 44. Global Sonidegib Sales Market Share by Region (2021-2026) Table 45. Global Sonidegib Sales by Region (2027-2032) & (Units) Table 46. Global Sonidegib Sales Market Share by Region (2027-2032) Table 47. Global Sonidegib Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sonidegib Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sonidegib Sales Value Share by Region (2021-2026) Table 50. Global Sonidegib Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sonidegib Sales Value Share by Region (2027-2032) Table 52. Global Sonidegib Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Sonidegib Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Sonidegib Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Sonidegib Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sonidegib Sales by Country (2021-2026) & (Units) Table 57. Global Sonidegib Sales Market Share by Country (2021-2026) Table 58. Global Sonidegib Sales by Country (2027-2032) & (Units) Table 59. Global Sonidegib Sales Market Share by Country (2027-2032) Table 60. Global Sonidegib Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sonidegib Sales Value Market Share by Country (2021-2026) Table 62. Global Sonidegib Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sonidegib Sales Value Market Share by Country (2027-2032) Table 64. Sun Pharmaceutical Industries Company Information Table 65. Sun Pharmaceutical Industries Business Overview Table 66. Sun Pharmaceutical Industries Sonidegib Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sun Pharmaceutical Industries Sonidegib Product Portfolio Table 68. Sun Pharmaceutical Industries Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Sonidegib Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Novartis Sonidegib Product Portfolio Table 73. Novartis Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Sonidegib Distributors List Table 77. Sonidegib Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Sonidegib Product Image Figure 2. Global Sonidegib Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sonidegib Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sonidegib Sales (2021-2032) & (Units) Figure 5. Global Sonidegib Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sonidegib Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Solution Image Figure 10. Capsule Image Figure 11. Global Sonidegib Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Sonidegib Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sonidegib Sales Volume Share by Type (2021-2032) Figure 14. Global Sonidegib Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sonidegib Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sonidegib Sales Value Share by Type (2021-2032) Figure 17. Treating Basal Cell Carcinoma Image Figure 18. Antitumor Image Figure 19. Others Image Figure 20. Global Sonidegib Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Sonidegib Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sonidegib Sales Volume Share by Application (2021-2032) Figure 23. Global Sonidegib Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sonidegib Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sonidegib Sales Value Share by Application (2021-2032) Figure 26. Global Sonidegib Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Sonidegib Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sonidegib Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sonidegib Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sonidegib Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sonidegib Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sonidegib Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sonidegib Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sonidegib Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sonidegib Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sonidegib Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sonidegib Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sonidegib Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sonidegib Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sonidegib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sonidegib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sonidegib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sonidegib Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sonidegib Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Solution
  • Capsule
Applications
  • Treating Basal Cell Carcinoma
  • Antitumor
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sonidegib Sales Value (2021-2032)
  4. 1.2.2 Global Sonidegib Sales Volume (2021-2032)
  5. 1.2.3 Global Sonidegib Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sonidegib Market Dynamics
  1. 2.1 Sonidegib Industry Trends
  2. 2.2 Sonidegib Industry Drivers
  3. 2.3 Sonidegib Industry Opportunities and Challenges
  4. 2.4 Sonidegib Industry Restraints
3 Sonidegib Market by Company
  1. 3.1 Global Sonidegib Company Revenue Ranking in 2025
  2. 3.2 Global Sonidegib Revenue by Company (2021-2026)
  3. 3.3 Global Sonidegib Sales Volume by Company (2021-2026)
  4. 3.4 Global Sonidegib Average Price by Company (2021-2026)
  5. 3.5 Global Sonidegib Company Ranking (2024-2026)
  6. 3.6 Global Sonidegib Company Manufacturing Base and Headquarters
  7. 3.7 Global Sonidegib Company Product Type and Application
  8. 3.8 Global Sonidegib Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sonidegib Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sonidegib Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sonidegib Market by Type
  1. 4.1 Sonidegib Type Introduction
  2. 4.1.1 Solution
  3. 4.1.2 Capsule
  4. 4.2 Global Sonidegib Sales Volume by Type
  5. 4.2.1 Global Sonidegib Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sonidegib Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sonidegib Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sonidegib Sales Value by Type
  9. 4.3.1 Global Sonidegib Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sonidegib Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sonidegib Sales Value Share by Type (2021-2032)
5 Sonidegib Market by Application
  1. 5.1 Sonidegib Application Introduction
  2. 5.1.1 Treating Basal Cell Carcinoma
  3. 5.1.2 Antitumor
  4. 5.1.3 Others
  5. 5.2 Global Sonidegib Sales Volume by Application
  6. 5.2.1 Global Sonidegib Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sonidegib Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sonidegib Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sonidegib Sales Value by Application
  10. 5.3.1 Global Sonidegib Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sonidegib Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sonidegib Sales Value Share by Application (2021-2032)
6 Sonidegib Regional Sales and Value Analysis
  1. 6.1 Global Sonidegib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sonidegib Sales by Region (2021-2032)
  3. 6.2.1 Global Sonidegib Sales by Region: 2021-2026
  4. 6.2.2 Global Sonidegib Sales by Region (2027-2032)
  5. 6.3 Global Sonidegib Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sonidegib Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sonidegib Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sonidegib Sales Value by Region (2027-2032)
  9. 6.5 Global Sonidegib Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sonidegib Sales Value (2021-2032)
  12. 6.6.2 North America Sonidegib Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sonidegib Sales Value (2021-2032)
  15. 6.7.2 Europe Sonidegib Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sonidegib Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sonidegib Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sonidegib Sales Value (2021-2032)
  21. 6.9.2 South America Sonidegib Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sonidegib Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sonidegib Sales Value Share by Country, 2025 VS 2032
7 Sonidegib Country-level Sales and Value Analysis
  1. 7.1 Global Sonidegib Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sonidegib Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sonidegib Sales by Country (2021-2032)
  4. 7.3.1 Global Sonidegib Sales by Country (2021-2026)
  5. 7.3.2 Global Sonidegib Sales by Country (2027-2032)
  6. 7.4 Global Sonidegib Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sonidegib Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sonidegib Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sonidegib Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sonidegib Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sonidegib Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sonidegib Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sonidegib Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sonidegib Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sonidegib Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sonidegib Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sonidegib Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sonidegib Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sonidegib Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sonidegib Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sonidegib Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sonidegib Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sonidegib Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sonidegib Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sonidegib Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sonidegib Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sonidegib Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sonidegib Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sonidegib Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sonidegib Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sonidegib Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sonidegib Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sonidegib Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sonidegib Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sonidegib Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sonidegib Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sonidegib Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sonidegib Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sonidegib Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sonidegib Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sonidegib Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sonidegib Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sonidegib Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sonidegib Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sonidegib Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sonidegib Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sonidegib Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sonidegib Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sonidegib Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sonidegib Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sonidegib Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sonidegib Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sonidegib Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sonidegib Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sonidegib Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sonidegib Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sonidegib Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sonidegib Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sonidegib Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sonidegib Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sonidegib Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sonidegib Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sonidegib Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sonidegib Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sonidegib Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sonidegib Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sonidegib Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sonidegib Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sonidegib Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sonidegib Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sonidegib Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sonidegib Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sonidegib Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sonidegib Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sonidegib Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sonidegib Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sonidegib Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sonidegib Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sonidegib Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sonidegib Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sonidegib Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sonidegib Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sonidegib Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sonidegib Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sonidegib Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sonidegib Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sonidegib Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sonidegib Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sonidegib Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sonidegib Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sonidegib Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sonidegib Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Sonidegib Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Sonidegib Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Sonidegib Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Sonidegib Product Portfolio
  12. 8.2.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sonidegib Value Chain Analysis
  2. 9.1.1 Sonidegib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sonidegib Sales Mode & Process
  6. 9.2 Sonidegib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sonidegib Distributors
  9. 9.2.3 Sonidegib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst